The effect of HIV on filarial-specific antibody response before and after treatment with diethylcarbamazine in Wuchereria bancrofti infected individuals.
Identifieur interne : 002A65 ( PubMed/Checkpoint ); précédent : 002A64; suivant : 002A66The effect of HIV on filarial-specific antibody response before and after treatment with diethylcarbamazine in Wuchereria bancrofti infected individuals.
Auteurs : Heidi H. Petersen [Danemark] ; Nina O. Nielsen ; Jesper Monrad ; Stephen M. Magesa ; Paul E. SimonsenSource :
- Parasitology international [ 1873-0329 ] ; 2009.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Animaux, Anticorps antihelminthe (sang), Charge virale, Diéthylcarbamazine (usage thérapeutique), Femelle, Filaricides (usage thérapeutique), Filariose lymphatique (), Filariose lymphatique (immunologie), Filariose lymphatique (parasitologie), Filariose lymphatique (traitement médicamenteux), Humains, Immunoglobuline G (sang), Infections à VIH (), Infections à VIH (immunologie), Infections à VIH (virologie), Jeune adulte, Mâle, Numération des lymphocytes CD4, Spécificité des anticorps, VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (immunologie), VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (physiologie), Wuchereria bancrofti (immunologie).
- MESH :
- immunologie : Filariose lymphatique, Infections à VIH, VIH-1 (Virus de l'Immunodéficience Humaine de type 1), Wuchereria bancrofti.
- parasitologie : Filariose lymphatique.
- physiologie : VIH-1 (Virus de l'Immunodéficience Humaine de type 1).
- sang : Anticorps antihelminthe, Immunoglobuline G.
- traitement médicamenteux : Filariose lymphatique.
- usage thérapeutique : Diéthylcarbamazine, Filaricides.
- virologie : Infections à VIH.
- Adulte, Adulte d'âge moyen, Animaux, Charge virale, Femelle, Filariose lymphatique, Humains, Infections à VIH, Jeune adulte, Mâle, Numération des lymphocytes CD4, Spécificité des anticorps.
English descriptors
- KwdEn :
- Adult, Animals, Antibodies, Helminth (blood), Antibody Specificity, CD4 Lymphocyte Count, Diethylcarbamazine (therapeutic use), Elephantiasis, Filarial (complications), Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (immunology), Elephantiasis, Filarial (parasitology), Female, Filaricides (therapeutic use), HIV Infections (complications), HIV Infections (immunology), HIV Infections (virology), HIV-1 (immunology), HIV-1 (physiology), Humans, Immunoglobulin G (blood), Male, Middle Aged, Viral Load, Wuchereria bancrofti (immunology), Young Adult.
- MESH :
- chemical , blood : Antibodies, Helminth, Immunoglobulin G.
- chemical , therapeutic use : Diethylcarbamazine, Filaricides.
- complications : Elephantiasis, Filarial, HIV Infections.
- drug therapy : Elephantiasis, Filarial.
- immunology : Elephantiasis, Filarial, HIV Infections, HIV-1, Wuchereria bancrofti.
- parasitology : Elephantiasis, Filarial.
- physiology : HIV-1.
- virology : HIV Infections.
- Adult, Animals, Antibody Specificity, CD4 Lymphocyte Count, Female, Humans, Male, Middle Aged, Viral Load, Young Adult.
Abstract
The effect of HIV on filarial-specific antibody response before and after treatment with diethylcarbamazine (DEC) was analysed by comparing two groups of Wuchereria bancrofti-infected adult individuals (positive for circulating filarial antigen) who were positive (n=15) or negative (n=21) for HIV co-infection. Prior to DEC treatment there was no significant difference in filarial-specific IgG1, IgG2, IgG4 and IgE antibody response between the HIV negative and the HIV positive group, while a five times (statistically significant) higher filarial-specific IgG3 response was observed in the HIV positive than in the HIV negative group. At 12 weeks after treatment with DEC, a significant decrease in filarial-specific IgG4 was observed in the HIV positive but not in the HIV negative group, indicating that DEC treatment had a stronger antifilarial effect in individuals co-infected with HIV. DEC treatment had no significant effect on the other classes of filarial specific antibodies, neither in the HIV negative or the HIV positive group.
DOI: 10.1016/j.parint.2009.01.003
PubMed: 19567236
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:19567236Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The effect of HIV on filarial-specific antibody response before and after treatment with diethylcarbamazine in Wuchereria bancrofti infected individuals.</title><author><name sortKey="Petersen, Heidi H" sort="Petersen, Heidi H" uniqKey="Petersen H" first="Heidi H" last="Petersen">Heidi H. Petersen</name><affiliation wicri:level="1"><nlm:affiliation>DBL-Centre for Health Research and Development, Faculty of Life Sciences, University of Copenhagen, Frederiksberg, Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>DBL-Centre for Health Research and Development, Faculty of Life Sciences, University of Copenhagen, Frederiksberg</wicri:regionArea><wicri:noRegion>Frederiksberg</wicri:noRegion></affiliation></author><author><name sortKey="Nielsen, Nina O" sort="Nielsen, Nina O" uniqKey="Nielsen N" first="Nina O" last="Nielsen">Nina O. Nielsen</name></author><author><name sortKey="Monrad, Jesper" sort="Monrad, Jesper" uniqKey="Monrad J" first="Jesper" last="Monrad">Jesper Monrad</name></author><author><name sortKey="Magesa, Stephen M" sort="Magesa, Stephen M" uniqKey="Magesa S" first="Stephen M" last="Magesa">Stephen M. Magesa</name></author><author><name sortKey="Simonsen, Paul E" sort="Simonsen, Paul E" uniqKey="Simonsen P" first="Paul E" last="Simonsen">Paul E. Simonsen</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2009">2009</date><idno type="RBID">pubmed:19567236</idno><idno type="pmid">19567236</idno><idno type="doi">10.1016/j.parint.2009.01.003</idno><idno type="wicri:Area/PubMed/Corpus">002E16</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002E16</idno><idno type="wicri:Area/PubMed/Curation">002E16</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002E16</idno><idno type="wicri:Area/PubMed/Checkpoint">002E16</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002E16</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The effect of HIV on filarial-specific antibody response before and after treatment with diethylcarbamazine in Wuchereria bancrofti infected individuals.</title><author><name sortKey="Petersen, Heidi H" sort="Petersen, Heidi H" uniqKey="Petersen H" first="Heidi H" last="Petersen">Heidi H. Petersen</name><affiliation wicri:level="1"><nlm:affiliation>DBL-Centre for Health Research and Development, Faculty of Life Sciences, University of Copenhagen, Frederiksberg, Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>DBL-Centre for Health Research and Development, Faculty of Life Sciences, University of Copenhagen, Frederiksberg</wicri:regionArea><wicri:noRegion>Frederiksberg</wicri:noRegion></affiliation></author><author><name sortKey="Nielsen, Nina O" sort="Nielsen, Nina O" uniqKey="Nielsen N" first="Nina O" last="Nielsen">Nina O. Nielsen</name></author><author><name sortKey="Monrad, Jesper" sort="Monrad, Jesper" uniqKey="Monrad J" first="Jesper" last="Monrad">Jesper Monrad</name></author><author><name sortKey="Magesa, Stephen M" sort="Magesa, Stephen M" uniqKey="Magesa S" first="Stephen M" last="Magesa">Stephen M. Magesa</name></author><author><name sortKey="Simonsen, Paul E" sort="Simonsen, Paul E" uniqKey="Simonsen P" first="Paul E" last="Simonsen">Paul E. Simonsen</name></author></analytic><series><title level="j">Parasitology international</title><idno type="eISSN">1873-0329</idno><imprint><date when="2009" type="published">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Animals</term><term>Antibodies, Helminth (blood)</term><term>Antibody Specificity</term><term>CD4 Lymphocyte Count</term><term>Diethylcarbamazine (therapeutic use)</term><term>Elephantiasis, Filarial (complications)</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (immunology)</term><term>Elephantiasis, Filarial (parasitology)</term><term>Female</term><term>Filaricides (therapeutic use)</term><term>HIV Infections (complications)</term><term>HIV Infections (immunology)</term><term>HIV Infections (virology)</term><term>HIV-1 (immunology)</term><term>HIV-1 (physiology)</term><term>Humans</term><term>Immunoglobulin G (blood)</term><term>Male</term><term>Middle Aged</term><term>Viral Load</term><term>Wuchereria bancrofti (immunology)</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Animaux</term><term>Anticorps antihelminthe (sang)</term><term>Charge virale</term><term>Diéthylcarbamazine (usage thérapeutique)</term><term>Femelle</term><term>Filaricides (usage thérapeutique)</term><term>Filariose lymphatique ()</term><term>Filariose lymphatique (immunologie)</term><term>Filariose lymphatique (parasitologie)</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Humains</term><term>Immunoglobuline G (sang)</term><term>Infections à VIH ()</term><term>Infections à VIH (immunologie)</term><term>Infections à VIH (virologie)</term><term>Jeune adulte</term><term>Mâle</term><term>Numération des lymphocytes CD4</term><term>Spécificité des anticorps</term><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (immunologie)</term><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (physiologie)</term><term>Wuchereria bancrofti (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Helminth</term><term>Immunoglobulin G</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Diethylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Elephantiasis, Filarial</term><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Filariose lymphatique</term><term>Infections à VIH</term><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Elephantiasis, Filarial</term><term>HIV Infections</term><term>HIV-1</term><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="parasitologie" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="parasitology" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>HIV-1</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antihelminthe</term><term>Immunoglobuline G</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Diéthylcarbamazine</term><term>Filaricides</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Animals</term><term>Antibody Specificity</term><term>CD4 Lymphocyte Count</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Viral Load</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Animaux</term><term>Charge virale</term><term>Femelle</term><term>Filariose lymphatique</term><term>Humains</term><term>Infections à VIH</term><term>Jeune adulte</term><term>Mâle</term><term>Numération des lymphocytes CD4</term><term>Spécificité des anticorps</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The effect of HIV on filarial-specific antibody response before and after treatment with diethylcarbamazine (DEC) was analysed by comparing two groups of Wuchereria bancrofti-infected adult individuals (positive for circulating filarial antigen) who were positive (n=15) or negative (n=21) for HIV co-infection. Prior to DEC treatment there was no significant difference in filarial-specific IgG1, IgG2, IgG4 and IgE antibody response between the HIV negative and the HIV positive group, while a five times (statistically significant) higher filarial-specific IgG3 response was observed in the HIV positive than in the HIV negative group. At 12 weeks after treatment with DEC, a significant decrease in filarial-specific IgG4 was observed in the HIV positive but not in the HIV negative group, indicating that DEC treatment had a stronger antifilarial effect in individuals co-infected with HIV. DEC treatment had no significant effect on the other classes of filarial specific antibodies, neither in the HIV negative or the HIV positive group.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19567236</PMID><DateCreated><Year>2009</Year><Month>11</Month><Day>03</Day></DateCreated><DateCompleted><Year>2010</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-0329</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>2</Issue><PubDate><Year>2009</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Parasitology international</Title><ISOAbbreviation>Parasitol. Int.</ISOAbbreviation></Journal><ArticleTitle>The effect of HIV on filarial-specific antibody response before and after treatment with diethylcarbamazine in Wuchereria bancrofti infected individuals.</ArticleTitle><Pagination><MedlinePgn>141-4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.parint.2009.01.003</ELocationID><Abstract><AbstractText>The effect of HIV on filarial-specific antibody response before and after treatment with diethylcarbamazine (DEC) was analysed by comparing two groups of Wuchereria bancrofti-infected adult individuals (positive for circulating filarial antigen) who were positive (n=15) or negative (n=21) for HIV co-infection. Prior to DEC treatment there was no significant difference in filarial-specific IgG1, IgG2, IgG4 and IgE antibody response between the HIV negative and the HIV positive group, while a five times (statistically significant) higher filarial-specific IgG3 response was observed in the HIV positive than in the HIV negative group. At 12 weeks after treatment with DEC, a significant decrease in filarial-specific IgG4 was observed in the HIV positive but not in the HIV negative group, indicating that DEC treatment had a stronger antifilarial effect in individuals co-infected with HIV. DEC treatment had no significant effect on the other classes of filarial specific antibodies, neither in the HIV negative or the HIV positive group.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Petersen</LastName><ForeName>Heidi H</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>DBL-Centre for Health Research and Development, Faculty of Life Sciences, University of Copenhagen, Frederiksberg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nielsen</LastName><ForeName>Nina O</ForeName><Initials>NO</Initials></Author><Author ValidYN="Y"><LastName>Monrad</LastName><ForeName>Jesper</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Magesa</LastName><ForeName>Stephen M</ForeName><Initials>SM</Initials></Author><Author ValidYN="Y"><LastName>Simonsen</LastName><ForeName>Paul E</ForeName><Initials>PE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Parasitol Int</MedlineTA><NlmUniqueID>9708549</NlmUniqueID><ISSNLinking>1383-5769</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000909">Antibodies, Helminth</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005369">Filaricides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>V867Q8X3ZD</RegistryNumber><NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000909" MajorTopicYN="N">Antibodies, Helminth</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000918" MajorTopicYN="N">Antibody Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018791" MajorTopicYN="N">CD4 Lymphocyte Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004605" MajorTopicYN="Y">Elephantiasis, Filarial</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005369" MajorTopicYN="N">Filaricides</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014958" MajorTopicYN="N">Wuchereria bancrofti</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year><Month>09</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2009</Year><Month>01</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2009</Year><Month>01</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>7</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>7</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19567236</ArticleId><ArticleId IdType="pii">S1383-5769(09)00004-X</ArticleId><ArticleId IdType="doi">10.1016/j.parint.2009.01.003</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Danemark</li></country></list><tree><noCountry><name sortKey="Magesa, Stephen M" sort="Magesa, Stephen M" uniqKey="Magesa S" first="Stephen M" last="Magesa">Stephen M. Magesa</name><name sortKey="Monrad, Jesper" sort="Monrad, Jesper" uniqKey="Monrad J" first="Jesper" last="Monrad">Jesper Monrad</name><name sortKey="Nielsen, Nina O" sort="Nielsen, Nina O" uniqKey="Nielsen N" first="Nina O" last="Nielsen">Nina O. Nielsen</name><name sortKey="Simonsen, Paul E" sort="Simonsen, Paul E" uniqKey="Simonsen P" first="Paul E" last="Simonsen">Paul E. Simonsen</name></noCountry><country name="Danemark"><noRegion><name sortKey="Petersen, Heidi H" sort="Petersen, Heidi H" uniqKey="Petersen H" first="Heidi H" last="Petersen">Heidi H. Petersen</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002A65 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002A65 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:19567236
|texte= The effect of HIV on filarial-specific antibody response before and after treatment with diethylcarbamazine in Wuchereria bancrofti infected individuals.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:19567236" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |